Prostate Cancer Clinical Trials in Raleigh, NC

Prostate Cancer Clinical Trials in Raleigh, NC

View the best 10 prostate cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Prostate Cancer clinical trial.

Top rated prostate cancer clinical trials in Raleigh, North Carolina

Here are the top 10 medical studies for prostate cancer in Raleigh, North Carolina

Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

Salvage Radiotherapy

Radiation

Recruiting1 awardPhase 2
This trial is testing whether radiation therapy and a stronger form of hormone therapy can improve survival for men with aggressive prostate cancer that has come back after surgery.
Image of Arizona Urology Specialists, PLLC in Tucson, United States.

Relugolix +1 More

Hormone Therapy

Recruiting2 awardsPhase 3
This trial will compare the risk of major heart events in prostate cancer patients taking Relugolix or Leuprolide Acetate. Ages 18+. On ADT for min. 1 year.
Image of Call for Information (Investigational Site 0005) in Los Angeles, United States.

Pembrolizumab +7 More

Checkpoint Inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety and efficacy of pembrolizumab in combination with other drugs for treating patients with mCRPC. There will be nine cohorts in the study, each receiving different combinations of drugs. Outcome measures will be assessed individually for each cohort.
Image of Research Site in Birmingham, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial is testing the combination of olaparib and abiraterone versus placebo and abiraterone to see if it is more effective and has fewer side effects in patients with mCRPC who have not received prior chemotherapy or NHAs.
Image of Mayo Clinic - Arizona in Phoenix, United States.

Rucaparib +3 More

PARP Inhibitor

Recruiting2 awardsPhase 3
This trial will compare the effects of rucaparib to those of other standard treatments for men with metastatic prostate cancer that has continued to grow despite castration and other treatments.
Image of Arizona in Phoenix, United States.

PT-112 Injection

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing a new cancer drug, PT-112. It is in two parts, the first of which has finished enrolling. The second part is testing PT-112's safety and how well it works in patients with thymoma or thymic carcinoma, and in patients with metastatic castrate-resistant prostate cancer.
Image of City of Hope National Medical Center in Duarte, United States.

Prednisone +2 More

Corticosteroid

Recruiting3 awardsPhase 2
This trial is testing a new cancer treatment for men with metastatic castration resistant prostate cancer. It is a 1:1:1 randomized open-label multicenter phase II study, which means that patients will be randomly assigned to one of three different treatment groups. The study will take place at multiple centers, and patients will be observed over the course of the trial.
Image of Mayo Clinic Hospital in Phoenix, United States.

Darolutamide +1 More

Androgen Receptor Inhibitor

Recruiting1 awardPhase 3
This trial is researching if a combination of ADT and darolutamide can help men with prostate cancer at high risk of biochemical recurrence (BCR) live longer without their cancer getting worse.
Image of Site US10011 in Tucson, United States.

Enzalutamide

Antiandrogen

Recruiting1 awardPhase 2
This trial is to study the long-term safety of subjects who are still benefiting from treatment with Enzalutamide.
Image of Washington University in Saint Louis, United States.

Tarlatamab

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new cancer drug to see if it is safe and how well it works.

Popular filter options for prostate-cancer raleigh trials

Phase 3 Clinical Trials

View 61 phase 3 medical studies.

Clinical Trials With No Placebo

View 61 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.